Machine Learning

The new Identity Command Center from KeyData Cyber offers security leaders real-time control, shifting identity management from fragmented projects to a unified program.

Deepvein Mining unveils DeepSight, an AI-driven system using drones and robot dogs to find minerals faster, cheaper, and more safely than ever before.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.

A key partnership aims to accelerate silicon carbide innovation, a critical component for the future of electric vehicles and renewable energy.

A new AI-driven system is tackling fraud and boosting transaction success in Ghana, offering a powerful blueprint for emerging digital economies worldwide.

Shanghai names Sanyou Bio a top municipal tech center, validating its AI-powered antibody library that's reshaping global drug R&D and fueling regional innovation.

In a strategic move to dominate the AI infrastructure boom, AVAIO Digital has hired industry pioneer Jason Norado to execute its multi-gigawatt expansion.

How a mortgage giant traded manual spreadsheets for custom AI, scaling loan volume 10x and saving millions, rewriting the playbook for growth.

Danish firm Evaxion, backed by the Gates Foundation, uses its AI platform to design a next-gen polio vaccine, aiming to end the disease for good.

Roche has received FDA clearance for two new high-speed diagnostic units designed to alleviate lab staff shortages and dramatically increase testing capacity.

With a fresh $6M infusion bringing its Series A to $36M, FIZE Medical is accelerating its global push for AI-powered, proactive fluid management in ICUs.

A new pocket-sized, AI-powered ultrasound aims to revolutionize prenatal care in Africa, putting life-saving diagnostics into the hands of local caregivers.

A new partnership between Takara Bio and Hamilton promises to revolutionize RNA-seq, making high-throughput genomic analysis faster and more reliable.

An amended deal with Tasly positions AP Biosciences to license its innovative bispecific cancer therapy to global pharma giants, targeting a lucrative market.

A new partnership aims to merge digital brain therapies with functional foods, targeting Japan and Southeast Asia's rapidly growing elderly populations.

A new drug not only reduces osteoarthritis pain significantly but may also be the first to modify the disease itself, a landmark study in The Lancet reveals.

South Korean AI chip leader Rebellions raises $400M, launching full-stack AI systems to redefine efficient inference and spearhead a global expansion.

Aurinia Pharmaceuticals' deal for Kezar Life Sciences hinges on zetomipzomib, a promising but risky drug poised to tackle a rare autoimmune liver disease.

With $8M in funding, Huskeys' new AI platform sits on top of existing firewalls, promising to stop blocking customers and start generating revenue.

LIB Therapeutics' new monthly, room-temperature stable cholesterol drug shows strong long-term data, challenging rivals with a focus on patient ease-of-use.